Diverse Roles of Heparan Sulfate and Heparin in Wound Repair

Heparan sulfate (HS) and heparin (Hp) are linear polysaccharide chains composed of repeating (1→4) linked pyrosulfuric acid and 2-amino-2-deoxy glucopyranose (glucosamine) residue. Mentioned glycosaminoglycans chains are covalently O-linked to serine residues within the core proteins creating heparan sulfate/heparin proteoglycans (HSPG). The latter ones participate in many physiological and pathological phenomena impacting both the plethora of ligands such as cytokines, growth factors, and adhesion molecules and the variety of the ECM constituents. Moreover, HS/Hp determine the effective wound healing process. Initial growth of HS and Hp amount is pivotal during the early phase of tissue repair; however heparan sulfate and heparin also participate in further stages of tissue regeneration.

[1]  M. Vermeij,et al.  RGTA OTR 4120, a heparan sulfate proteoglycan mimetic, increases wound breaking strength and vasodilatory capability in healing rat full‐thickness excisional wounds , 2008, Wound repair and regeneration : official publication of the Wound Healing Society [and] the European Tissue Repair Society.

[2]  L. Borsig,et al.  Sulfated hexasaccharides attenuate metastasis by inhibition of P-selectin and heparanase. , 2011, Neoplasia.

[3]  P. Olczyk,et al.  Propolis Induces Chondroitin/Dermatan Sulphate and Hyaluronic Acid Accumulation in the Skin of Burned Wound , 2013, Evidence-based complementary and alternative medicine : eCAM.

[4]  B. Hinz,et al.  The myofibroblast matrix: implications for tissue repair and fibrosis , 2013, The Journal of pathology.

[5]  G. David,et al.  Developmental roles of the glypicans. , 2001, Seminars in cell & developmental biology.

[6]  K. Midwood,et al.  The role of tenascin-C in tissue injury and tumorigenesis , 2009, Journal of Cell Communication and Signaling.

[7]  N. Smits,et al.  Anticoagulant heparan sulfate to not clot--or not? , 2010, Progress in molecular biology and translational science.

[8]  Arthur D Lander,et al.  Glypican-1 controls brain size through regulation of fibroblast growth factor signaling in early neurogenesis , 2009, Neural Development.

[9]  J. Couchman,et al.  Perlecan and Tumor Angiogenesis , 2003, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[10]  Dragana Nikitovic,et al.  Glycosaminoglycans: key players in cancer cell biology and treatment , 2012, The FEBS journal.

[11]  H. Kim,et al.  Fibroblast Growth Factors: Biology, Function, and Application for Tissue Regeneration , 2010, Journal of tissue engineering.

[12]  P. Peplow.  Glycosaminoglycan: a candidate to stimulate the repair of chronic wounds , 2005, Thrombosis and Haemostasis.

[13]  Yunliang Chen,et al.  Matrix Contraction by Dermal Fibroblasts Requires Transforming Growth Factor-β/Activin-Linked Kinase 5, Heparan Sulfate-Containing Proteoglycans, and MEK/ERK , 2005 .

[14]  P. Olczyk,et al.  Propolis modulates vitronectin, laminin, and heparan sulfate/heparin expression during experimental burn healing , 2012, Journal of Zhejiang University SCIENCE B.

[15]  Yunliang Chen,et al.  Matrix contraction by dermal fibroblasts requires transforming growth factor-beta/activin-linked kinase 5, heparan sulfate-containing proteoglycans, and MEK/ERK: insights into pathological scarring in chronic fibrotic disease. , 2005, The American journal of pathology.

[16]  Rahul Raman,et al.  Glycomics approach to structure-function relationships of glycosaminoglycans. , 2006, Annual review of biomedical engineering.

[17]  C. Parish,et al.  Heparan Sulfate: A Ubiquitous Glycosaminoglycan with Multiple Roles in Immunity , 2013, Front. Immunol..

[18]  F. Maquart,et al.  Cell surface proteoglycan expression during maturation of human monocytes‐derived dendritic cells and macrophages , 2006, Clinical and experimental immunology.

[19]  G. Schultz,et al.  Interactions between extracellular matrix and growth factors in wound healing , 2009, Wound repair and regeneration : official publication of the Wound Healing Society [and] the European Tissue Repair Society.

[20]  L. DiPietro,et al.  Factors Affecting Wound Healing , 2010, Journal of dental research.

[21]  M. Lyon,et al.  Hepatocyte growth factor/scatter factor and its interaction with heparan sulphate and dermatan sulphate. , 2003, Biochemical Society transactions.

[22]  R. Diegelmann,et al.  Wound healing: an overview of acute, fibrotic and delayed healing. , 2004, Frontiers in bioscience : a journal and virtual library.

[23]  S. Perkins,et al.  Molecular Interactions between Complement Factor H and Its Heparin and Heparan Sulfate Ligands , 2014, Front. Immunol..

[24]  J. Otlewski,et al.  Increased Protein Stability of FGF1 Can Compensate for Its Reduced Affinity for Heparin* , 2009, The Journal of Biological Chemistry.

[25]  S. Nelson,et al.  The potential role of heparin in assisted conception. , 2008, Human reproduction update.

[26]  L. Haupt,et al.  Mesenchymal stem cells, neural lineage potential, heparan sulfate proteoglycans and the matrix. , 2014, Developmental biology.

[27]  Alan Wells,et al.  Extracellular matrix signaling through growth factor receptors during wound healing , 2004, Wound repair and regeneration : official publication of the Wound Healing Society [and] the European Tissue Repair Society.

[28]  M. Mytilinaiou,et al.  Heparan sulfate proteoglycans and heparin regulate melanoma cell functions. , 2014, Biochimica et biophysica acta.

[29]  J. Zaia,et al.  Heparan sulfate-protein binding specificity , 2013, Biochemistry (Moscow).

[30]  Olivera Stojadinovic,et al.  PERSPECTIVE ARTICLE: Growth factors and cytokines in wound healing , 2008, Wound repair and regeneration : official publication of the Wound Healing Society [and] the European Tissue Repair Society.

[31]  T. Handel,et al.  Regulation of protein function by glycosaminoglycans--as exemplified by chemokines. , 2005, Annual review of biochemistry.

[32]  F. R. Melo,et al.  Mast Cell Proteoglycans , 2012, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[33]  F. Maccari,et al.  Electrophoretic approaches to the analysis of complex polysaccharides. , 2006, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[34]  M. Belting,et al.  Heparan sulfate proteoglycan as a cell-surface endocytosis receptor. , 2014, Matrix biology : journal of the International Society for Matrix Biology.

[35]  S. Prakash,et al.  Complements and the Wound Healing Cascade: An Updated Review , 2013, Plastic surgery international.

[36]  R. Sanderson,et al.  Heparan sulfate proteoglycans in invasion and metastasis. , 2001, Seminars in cell & developmental biology.

[37]  P. Olczyk,et al.  Propolis Modulates Fibronectin Expression in the Matrix of Thermal Injury , 2014, BioMed research international.

[38]  P. Berger,et al.  Therapeutic Targeting of Redox Signaling in Myofibroblast Differentiation and Age-Related Fibrotic Disease , 2012, Oxidative medicine and cellular longevity.

[39]  L. Kjellén,et al.  Pathophysiology of heparan sulphate: many diseases, few drugs , 2013, Journal of internal medicine.

[40]  J. Couchman,et al.  Regulation of cytoskeletal organization by syndecan transmembrane proteoglycans. , 2003, Matrix biology : journal of the International Society for Matrix Biology.

[41]  R. Kirsner,et al.  Dynamic reciprocity in the wound microenvironment , 2011, Wound repair and regeneration : official publication of the Wound Healing Society [and] the European Tissue Repair Society.

[42]  D. Baker,et al.  Stromal-Cell-Derived Factor-1 (SDF-1)/CXCL12 as Potential Target of Therapeutic Angiogenesis in Critical Leg Ischaemia , 2012, Cardiology research and practice.

[43]  Xinhua Lin,et al.  Functions of heparan sulfate proteoglycans in cell signaling during development , 2004, Development.

[44]  B. Pilawa,et al.  Positive Effect of Propolis on Free Radicals in Burn Wounds , 2013, Evidence-based complementary and alternative medicine : eCAM.

[45]  Fiona M Watt,et al.  Cell-extracellular matrix interactions in normal and diseased skin. , 2011, Cold Spring Harbor perspectives in biology.

[46]  G. Torri,et al.  Heparin-derived heparan sulfate mimics to modulate heparan sulfate-protein interaction in inflammation and cancer. , 2010, Matrix biology : journal of the International Society for Matrix Biology.

[47]  A. Theocharis,et al.  Heparan sulfate: biological significance, tools for biochemical analysis and structural characterization. , 2011, Biomedical chromatography : BMC.

[48]  R. Gallo,et al.  Glycosaminoglycans and their proteoglycans: host‐associated molecular patterns for initiation and modulation of inflammation , 2006, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[49]  H. Nader,et al.  Heparan sulfate proteoglycans: structure, protein interactions and cell signaling. , 2009, Anais da Academia Brasileira de Ciencias.

[50]  A. Wärri,et al.  Ectopic expression of syndecan-1 in basal epidermis affects keratinocyte proliferation and wound re-epithelialization. , 2008, The Journal of investigative dermatology.

[51]  Neha S. Gandhi,et al.  The Structure of Glycosaminoglycans and their Interactions with Proteins , 2008, Chemical biology & drug design.

[52]  M. Belting.  Heparan sulfate proteoglycan as a plasma membrane carrier. , 2003, Trends in biochemical sciences.

[53]  M. Ågren,et al.  The Extracellular Matrix in Wound Healing: A Closer Look at Therapeutics for Chronic Wounds , 2007, The international journal of lower extremity wounds.

[54]  Youping Deng,et al.  HGF Accelerates Wound Healing by Promoting the Dedifferentiation of Epidermal Cells through β 1-Integrin/ILK Pathway , 2013, BioMed research international.

[55]  J. Couchman,et al.  Syndecans as receptors and organizers of the extracellular matrix , 2009, Cell and Tissue Research.

[56]  R. Müller,et al.  Heparanase is expressed in osteoblastic cells and stimulates bone formation and bone mass , 2006, Journal of cellular physiology.

[57]  B. Mulloy,et al.  Cytokines and proteoglycans: an introductory overview. , 2006, Biochemical Society transactions.

[58]  R. Iozzo,et al.  Basement membrane proteoglycans: Modulators Par Excellence of cancer growth and angiogenesis , 2009, Molecules and cells.

[59]  Lianchun Wang,et al.  Endothelial heparan sulfate in angiogenesis. , 2010, Progress in molecular biology and translational science.

[60]  Rahul Raman,et al.  Structural insights into biological roles of protein-glycosaminoglycan interactions. , 2005, Chemistry & biology.

[61]  C. Page.  Heparin and Related Drugs: Beyond Anticoagulant Activity , 2013, ISRN pharmacology.

[62]  P. Seeberger,et al.  Chemical approaches to define the structure-activity relationship of heparin-like glycosaminoglycans. , 2005, Chemistry & biology.

[63]  Paul Martin,et al.  A Syndecan-4 Hair Trigger Initiates Wound Healing through Caveolin- and RhoG-Regulated Integrin Endocytosis , 2011, Developmental cell.

[64]  P. Olczyk,et al.  Propolis Modifies Collagen Types I and III Accumulation in the Matrix of Burnt Tissue , 2013, Evidence-based complementary and alternative medicine : eCAM.

[65]  N. Perrimon,et al.  Developmental cell biology: Heparan sulphate proteoglycans: the sweet side of development , 2005, Nature Reviews Molecular Cell Biology.

[66]  J. Rast,et al.  Glypicans , 2008, Genome Biology.

[67]  J. Esko,et al.  Heparan sulfate proteoglycans. , 2011, Cold Spring Harbor perspectives in biology.

[68]  Teng Fei,et al.  MCP-1 mediates TGF-beta-induced angiogenesis by stimulating vascular smooth muscle cell migration. , 2007, Blood.

[69]  Nicola Volpi,et al.  Therapeutic applications of glycosaminoglycans. , 2006, Current medicinal chemistry.

[70]  J. Cai,et al.  Effect of Heparin on Production of Transforming Growth Factor (TGF)-&bgr;1 and TGF-&bgr;1 mRNA Expression by Human Normal Skin and Hyperplastic Scar Fibroblasts , 2008, Annals of plastic surgery.